[1] 贾俊亚, 丁国华.肾脏中肾素-血管紧张素系统的生理和病理生理作用[J].生理科学进展, 2008, 39(1):71-74. [2] Sadjadi J, Kramer G, Yu C, et al.Angiotensin converting enzyme-independent angiotensin II production by chymase is up-regulated in the ischemic kidney in renovascular hypertension[J].J Surg Res, 2005, 127(2):65-69. [3] Lavoie JL, Lake-Bruse KD, Sigmund CD.Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule[J].Am J Physiol Renal, 2004, 286(5):F965-F971. [4] Prieto-Carrasquero MC, Botros FT, Pagan J, et al.Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip goldblatt hypertensive rats[J].Hypertension, 2008, 51(6):1590-1596. [5] Kobori H, Nishiyama A, Harrison-Bernard LM, et al.Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension[J].Hypertension, 2004, 41(1):42-49. [6] Prieto-Carrasquero MC, Kobori H, Qzawa Y, et al.AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats[J].Am J Physiol, 2005, 289(3):F632-F637. [7] 贾俊亚, 丁国华, 陈铖, 等.血管紧张素Ⅱ 灌注诱导大鼠肾脏血管紧张素转换酶2 表达改变[J].中华肾脏病杂志, 2007, 23(7):458-463. [8] Kobori H, Ozawa Y, Suzaki Y, et al.Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats[J].J Am Soc Nephrol, 2005, 16(10):2073-2080. [9] Jaimes EA, ZhouMS, Pearse DD, et al.Upregulation of cortical COX-2 in salt-sensitive hypertension:role of angiotensin II and reactive oxygen species[J].Am J Physiol Renal Physiol, 2008, 294(2):F385-392. [10] Navar LG, Nishiyama A.Why are angiotensin concentrations so high in the kidney[J] ? Curr Opin Nephrol Hypertens, 2004, 13(1):10-15. [11] Kobori H, Katsurada A, Ozawa Y, et al.Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients[J].Biochem Biophys Res Commun, 2007, 358(1):156-163. [12] Chan LY, Leung JC, Tang SC, et al.Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy[J].J Am Soc Nephrol, 2005, 16(10):2306-2317. [13] Xiao J, Leung JC, Chan LY, et al.Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy[J].Nephrol Dial Transplant, 2009, 24(7): 2067-2077. [14] Mezzano SA, Aros CA, Droguett A, et al.Renal angiotensin II up-regulation and myofibroblast activation in human membranous nephropathy[J].Kidney Int, 2003, 64(S1):S39-S45. [15] Shin GT, Kim WH, Yim H, et al.Effects of suppressing intrarenal angiotensinogen on renal transforming growth factor-beta1 expression in acute ureteral obstruction[J]. Kidney Int, 2005, 67(3):897-908. [16] Wu MS, Yang CW, Chang CT, et al.Cyclosporin increases the density of angiotensin II subtype 1 (AT1) receptors in mouse medullary thick ascending limb cells[J]. Nephrol Dial Transplant, 2003, 18(10):1458-1465. [17] Iijima K, Hamahira K, Kobayashi A, et al.Immunohistochemical analysis of renin activity in chronic cyclosporine nephropathy in childhood nephrotic syndrome[J].J Am Soc Nephrol, 2003, 11(11):2265-2271. [18] Loghman-Adham M, Soto CE, Inagami T, et al.The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease[J].Am J Physiol, 2004, 287(5):F775-F788. [19] Kelly DJ, Skinner SL, Gilbert RE, et al.Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat[J].Kidney Int, 2000, 57(10):1882-1894. [20] Sharma R, Sharma M, Reddy S, et al.Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes[J].Front Biosci, 2006, 11(4):968-976. [21] Huang XR, Chen WY, Truong LD, et al.Chymase is upregulated in diabetic nephropathy:implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease[J].J Am Soc Nephrol, 2003, 14(9):1738-1747. [22] Fliser D, Wagner KK, Loos A, et al.Chronic angiotensin II receptor blockade reduces (intra)renal vascular resistance in patients with type 2 diabetes[J].J Am Soc Nephrol, 2005, 16(7):1135-1140. [23] Faraggiana T, Venkataseshan VS, Inagami T, et al.Immunohistochemical localization of renin in end-stage kidneys[J].Am J Kidney Dis, 1998, 12(1):194-199. [24] Mann JF, Schmieder RE, McQueen M, et al.Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study):A multicentre, randomised, double-blind, controlled trial[J].Lancet, 2008, 372(2):547-553. [25] Berns JS.Is angiotensin-converting enzyme inhibitor and angiotensin receptor blocker combination therapy better than monotherapy and safe in patients with CKD[J] ? Am J Kidney Dis, 2009, 53(2):192-196. [26] Mehdi UF, Adams-Huet B, Raskin P, et al.Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy[J].Am Soc Nephrol, 2009 Nov 19.PMID:19926893 [Epub ahead of print] [27] Fan YY, Baba R, Nagai Y, et al.Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone salt-treated hypertensive rats;renoprotective effects of an ultrahigh dose of olmesartan[J].Hypertens Res, 2006, 29(1):169-178. |